![H. Parker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
H. Parker
Président chez SANGAMO THERAPEUTICS, INC.
Fortune : 396 194 $ au 31/05/2024
Provenance du réseau au premier degré de H. Parker
Entité | Type d'entité | Industrie | |
---|---|---|---|
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA.
228
| College/University | Other Consumer Services | 228 |
Public Company | Biotechnology | 59 | |
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation
34
| Subsidiary | Biotechnology | 34 |
Public Company | Chemicals: Specialty | 22 | |
Public Company | Pharmaceuticals: Major | 17 | |
Global Partnerships
![]() Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA.
17
| Non-Profit Organization | Financial Conglomerates | 17 |
Public Company | Biotechnology | 16 | |
AmpliPhi Biosciences Corp.
![]() AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.
16
| Extinct | Biotechnology | 16 |
StrideBio, Inc.
![]() StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC.
12
| Holding Company | Biotechnology | 12 |
Public Company | Pharmaceuticals: Major | 11 | |
Neose Technologies, Inc.
![]() Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market.
5
| Extinct | Pharmaceuticals: Major | 5 |
Inventprise LLC
![]() Inventprise LLC Pharmaceuticals: MajorHealth Technology Inventprise LLC is a private company that is developing vaccines against infectious diseases, with a focus on invasive pneumococcal disease, using their innovative platform technology. The company is based in Redmond, WA. The company also offers contract services in biologics, including process development, optimization, analytical services, and manufacturing from early clinical trials through commercialization. The company was founded by Subhash Vinayak Kapre, who has been the CEO since incorporation.
4
| Private Company | Pharmaceuticals: Major | 4 |
C3J Therapeutics, Inc.
![]() C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA.
4
| Subsidiary | Biotechnology | 4 |
Infectious Disease Research Institute
![]() Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA.
4
| Private Company | Miscellaneous Commercial Services | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à H. Parker via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Comptroller/Controller/Auditor | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ID Biomedical Corp.
![]() ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Medical Specialties | Chairman President Chief Operating Officer | |
ABAXIS INC | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman Chief Executive Officer | |
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
C3 Jian LLC
![]() C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Biotechnology | Director/Board Member Chief Executive Officer Chief Operating Officer Corporate Officer/Principal | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
University of California, Los Angeles | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
RESPONSE BIOMEDICAL CORP | Miscellaneous Commercial Services | Chairman Director/Board Member Chief Operating Officer | |
Global Partnerships (Private Equity)
![]() Global Partnerships (Private Equity) Investment ManagersFinance Global Partnerships (Private Equity)(Global Partnerships) is a private equity subsidiary of Global Partnerships firm founded in 1994. The firm is headquartered in Seattle, Washington. | Investment Managers | Chief Executive Officer Director/Board Member Private Equity Investor | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
Harvard Business School | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Columbia Law School | College/University | Graduate Degree Graduate Degree | |
Direct Relief
![]() Direct Relief Miscellaneous Commercial ServicesCommercial Services Direct Relief provides medical assistance to improve the quality of life for people affected by poverty, disaster, and civil unrest at home and throughout the world. Direct Relief works to support the work of healthcare providers, equipping them with the medicines, supplies and equipment. The company is headquartered in Santa Barbara, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
RELYPSA INC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Gen-Probe, Inc.
![]() Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Medical Specialties | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
AVITA Medical Pty Ltd.
![]() AVITA Medical Pty Ltd. BiotechnologyHealth Technology Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
San Diego State University | College/University | Undergraduate Degree Masters Business Admin | |
Program for Appropriate Technology in Health
![]() Program for Appropriate Technology in Health Miscellaneous Commercial ServicesCommercial Services Program for Appropriate Technology in Health provides social healthcare services. Its platform includes vaccines, drugs, diagnostics and devices. The firm offers treatment for malaria, pneumonia and diarrheal. The company was founded in 1977 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
Bioscience Managers Pty Ltd.
![]() Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Investment Managers | Director/Board Member Private Equity Investor | |
AVITA MEDICAL, INC. | Medical Specialties | Director/Board Member Chief Executive Officer | |
EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Renown Pharmaceuticals Pvt Ltd.
![]() Renown Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Renown Pharmaceuticals Pvt Ltd. manufactures pharmaceutical products. The private company is based in Vadodara, India. The company was founded in 2005. Richard Alistair Balfour Stewart has been the CEO of the Indian company since 2016. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Zogenix International Ltd.
![]() Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Pharmaceuticals: Major | Chairman Director/Board Member | |
eGenesis, Inc.
![]() eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Integrated Diagnostics, Inc.
![]() Integrated Diagnostics, Inc. Medical/Nursing ServicesHealth Services Integrated Diagnostics, Inc. operates as a molecular diagnostics firm. It develops diagnostics and measurement technologies that has a capability of measuring biomarkers for diagnosis and management of complex diseases. The company was founded by Jim Heath, David J. Galas, Leroy E. Hood, and Paul Edward Kearney and is headquartered Seattle, WA. | Medical/Nursing Services | Director/Board Member Director of Finance/CFO | |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chairman Director/Board Member | |
The Rockefeller University | College/University | Corporate Officer/Principal Graduate Degree | |
University of California | College/University | Undergraduate Degree Graduate Degree |
Statistiques
Internationale
Etats-Unis | 42 |
Canada | 3 |
Royaume-Uni | 3 |
Irlande | 2 |
Australie | 2 |
Sectorielle
Health Technology | 26 |
Consumer Services | 11 |
Commercial Services | 9 |
Finance | 4 |
Health Services | 3 |
Opérationnelle
Director/Board Member | 483 |
Corporate Officer/Principal | 187 |
Independent Dir/Board Member | 137 |
Chairman | 110 |
Chief Executive Officer | 91 |
Relations les plus connectées
Insiders | |
---|---|
Jeremy Curnock-Cook | 60 |
Steven Gillis | 58 |
William Ringo | 32 |
Karen Smith | 29 |
Patrick Yang | 28 |
Ali Satvat | 28 |
Michael Perry | 28 |
Robert Carey | 23 |
Dennis Wolf | 23 |
Todd R. Patrick | 22 |
Rahul Singhvi | 22 |
Michael T. Galgon | 21 |
Stephen Brown Davis | 21 |
Clay Thorp | 20 |
Sarah Schlesinger | 19 |